COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS

• 收藏
• 分享

专利权人:

Alnylam Pharmaceuticals; Inc.

发明人:

Novobrantseva, Tatiana,Bettencourt, Brian,Hinkle, Greg,Kotelianski, Victor,Sehgal, Alfica

申请号：

AU2019275561

公开号：

AU2019275561A1

申请日:

2019.12.03

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2019275561A120200102.pdf#####The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the COL1A1, TGF-beta, and SMAD2/3 genes, and methods of using such dsRNA compositions to inhibit expression of COL1A1, TGF-beta, and SMAD2/3.WO 2011/153323 PCT/US2O11/038889 13/19 00 Cl) 0 LL 0f QI) ' CfJ >； 0 C:~ CN tm 0 U, 0 -oTo m1 c >；-T -T E EY 0 "r) "- 0 Lu - 0 VNWU-DLL0 000

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/